002437 誉衡药业
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资66,908-0.18%67,03168,29368,544282,144
投资性房地产32,708-1.49%33,20434,50532,47433,666
固定资产946,086-3.67%982,1011,023,7431,055,5691,106,544
在建工程751-45.10%1,3681,8853,04512,890
无形资产147,016-9.79%162,977166,662191,300221,182
商誉369,0320.00%369,032369,032369,032369,032
其他非流动资产294,17547.07%200,019283,799278,036232,530
1,856,6762.25%1,815,7321,947,9181,998,0002,257,988

流动资产
货币资金497,04825.39%396,396481,963711,2751,237,743
应收账款120,237-5.03%126,608124,884205,240228,592
存货191,411-7.03%205,877188,672190,667214,136
其他流动资产596,7311.15%589,96681,67747,268135,726
1,405,4276.56%1,318,846877,1941,154,4501,816,198

流动负债
短期借款87,333-3.03%90,0580675,6901,454,973
应付票据0--0000
应付帐款71,0999.16%65,13260,44669,87675,481
其他流动负债587,599-8.57%642,659762,587665,584805,856
746,031-6.49%797,849823,0341,411,1502,336,310
流动资产净值659,39726.56%520,99754,161(256,701)(520,112)
资产总额减流动负债2,516,0737.68%2,336,7282,002,0791,741,3001,737,876

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债25,918-4.55%27,15429,22731,06934,335
25,918-4.55%27,15429,22731,06934,335

总权益
    实收股本2,229,868-0.10%2,232,0282,279,7502,198,1232,198,123
    储备项目241,035291.01%61,644(329,053)(536,350)(566,885)
股东权益2,470,9037.73%2,293,6721,950,6971,661,7731,631,238
非控股权益19,25121.06%15,90222,15548,45772,304